 |
市场调查报告书
商品编码
1438442
自动取样器：市场占有率分析、产业趋势/统计、成长预测 (2024-2029)Autosamplers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
自动取样器市场规模预计到 2024 年为 14.2 亿美元，预计到 2029 年将达到 20 亿美元，在预测期内（2024-2029 年）复合年增长率为 7.05%。
市场受到疫情的正面影响。由于COVID-19感染疾病数量的增加，对包括层析法技术在内的各种服务的需求也产生了积极影响并且不断增长。研究人员正在寻求疫苗和治疗方法。层析法是一种基于实验室的强大分析技术，可帮助科学界了解 Sars-CoV-2 病毒并开发更好的治疗方法、疫苗和诊断工具，以帮助对抗COVID-19 大流行。正在努力做到这一点的同时，研究人员正在采用它。例如，2020 年 6 月发表在《临床化学和实验医学》杂誌上的一项研究使用液相层析法和质谱法来量化COVID-19 患者血浆中的再输送，并发现SARS-CoV-2 作为治疗剂的有效性资料。
此外，已发表的论文表明胆固醇氧化产物可用于对抗 SARS-CoV-2。儘管有些患者对紧急抗病毒药物反应良好，但 SARS-CoV-2 需要安全有效的抗病毒药物。层析法系统在医疗、学术和商业设施中的重要性日益增加，表明该技术正在为各个领域的研究和开发做出重大贡献。例如，Encyclopedia Journal 于 2022 年 9 月发表的报导指出，能够支持后基因组和后 COVID-19 时代的苛刻要求的分析平台的坚实基础是易于获得、灵敏、解析能力强，由各种具有极高容量的强大层析法仪器提供。因此，由于后基因组和后 COVID-19 时代的要求，医疗设施对各种颜色系统的需求不断增加，这对自动取样器市场产生了积极影响。
推动市场成长的具体因素包括自动取样器的主导地位、层析法在药物核准中日益重要的地位以及对食品安全日益增长的担忧。自动取样器的作用不仅仅是切换样品和分析它们。自动取样器旨在支援灵活有效的工作流程，从减少流程订单和样品资讯中的转录错误到保护复杂的样品进行清洗和分析。根据 ModuVision Technologies 于 2021 年 9 月发表的报导，使用自动取样器的两个主要原因是它们高效，因为它们可以在不影响实验室员工的情况下处理许多样本。这与存在和品质有关。製药业进行广泛的研究来创造新药，增加了对成品的需求。
此外，根据 2022 年 6 月出版的《国际药物研究与应用期刊》，层析法被认为是一种灵敏且有效的分离方法。层析法应用于所有实验室、製药工业、学术机构等，是分离科学的基础。开发新药需要使用适当的技术，使科学家能够以最准确、最精确和最容易理解的方式评估药物分子。层析法凭藉其可靠、稳健的分辨率、速度和灵敏度，可提供更多信息，从而提高化学和设备工艺的生产率。因此，层析法的使用不断增加以及在药物开发中的重要性日益提高预计将加速市场成长。
然而，由于缺乏熟练的专业人员以及中小型市场参与者的预算限制，预计市场成长将受到限制。
自动取样器市场趋势
预计製药和生物技术公司在预测期内将出现高速成长
自动取样器透过自动选择样品并将其插入仪器入口来取代手动进样和进样。推动该行业成长的因素包括自动取样器为公司带来的好处以及层析法在药物核准中日益重要的角色。根据 Rasayanika 2020 年 10 月发表的报导，层析法技术用于识别和分析样品中是否存在化学物质和微量元素，製备大量高纯度物质，分离手掌性化合物，确定混合物的纯度，它用于在製药业界执行各种任务，包括化合物鑑定和药物开发。安捷伦科技表示，在适应性强的高效液相层析（HPLC）技术的支持下，（生物）製药研究人员和生产设施可以全面表征潜在的药物和治疗方法方案，可以确保药物的生产安全可靠。因此，这些特征预计将推动细分市场的成长。
此外，由于研发支出的增加，预计製药业的市场在预测期内将出现良好的成长。根据EP新闻局发表的报导称，2021年2月，政府将对投资新治疗方法、化学实体或新生物实体研究以抗击疫情的公司施加200%的权重。生物製药的考虑扣除和专案拨款研究与开发。这进一步增加了国外的研发投入。这些措施将被考虑用于未来的津贴和一系列迷你预算，以在支持性法规环境下支持策略发展。主要企业的先进产品预计将推动该领域的成长。例如，ESI DX自动取样器采用化学惰性结构，可为 Thermo Scientific 的 ICP-OES 和 ICP-MS 仪器提供无污染采样。主要企业的这些产品开发预计将推动市场的细分成长。
因此，预计上述因素将在预测期内推动市场的细分成长。
北美预计将主导自动取样器市场
由于主要市场参与者（尤其美国）的研发资金不断增加，北美在全球市场中占据主导地位。例如，根据《2022 年美国科学与工程状况》，美国在研发活动上花费了 6,075 亿美元，其中年度研发支出中有 1,011 亿美元（17%）被归类为初级研究。同样，美国的大部分研发都是由企业部门资助的，其中超过 98% 的资金用于支持商业性研发活动。第二大研发资金来源是美国联邦政府，约占21%，为所有产业的研发提供资金。美国不断增加的研发资金预计将推动市场发展。
该地区产品发布的增加预计将推动该地区的市场。例如，2022 年 3 月，Thermo Fisher Scientific 将推出新的 GC/GC-MS 仪器产品组合以提高效率。全新 Thermo Scientific TRACE 1600 系列气相层析、Thermo Scientific AI/AS 1610 液体自动取样器、Thermo Scientific ISQ 7610单四极GC-MS、Thermo Scientific TSQ 9610四极GC-MS GC/GC-MS仪器组合，包括/MS、现在的特点是技术进步，提高了易用性和生产力。主要企业推出此类产品预计将增加製药和食品和饮料行业药物发现的生产研发投资，并增加该地区对自动取样器的需求。
自动取样器产业概述
自动取样器市场本质上是整合的，存在着少数在全球和区域运营的公司。竞争形势包括自动取样器市场的重要参与者，包括Agilent Technologies、Bio-Rad Laboratories, Inc.、Gilson, Inc.、PerkinElmer, Inc.、Restek Corporation、Scion Instruments、Shimadzu Corporation、Thermo Fisher Scientific 和Waters Corporation 。它包括对几家占据市场占有率的知名国际和本地公司的分析。
其他福利：
- Excel 格式的市场预测 (ME) 表
- 3 个月分析师支持
目录
第一章 简介
- 研究假设和市场定义
- 调查范围
第二章调查方法
第三章执行摘要
第四章市场动态
- 市场概况
- 市场驱动因素
- 自动取样器的各种优点以及层析法在药物核准中日益重要的重要性
- 人们对食品安全的兴趣日益浓厚
- 市场限制因素
- 缺乏熟练的专业人员
- 中小型市场参与者的预算限制
- 波特五力分析
- 新进入者的威胁
- 买家/消费者的议价能力
- 供应商的议价能力
- 替代品的威胁
- 竞争公司之间敌对关係的强度
第五章市场区隔
- 副产品
- 系统
- 液相层析法自动取样器
- 气相层析法自动取样器
- 配件
- 系统
- 按最终用户
- 製药/生物製药公司
- 食品和饮料业
- 环境检测产业
- 其他的
- 按地区
- 北美洲
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 其他欧洲国家
- 亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 其他亚太地区
- 中东/非洲
- GCC
- 南非
- 其他中东和非洲
- 南美洲
- 巴西
- 阿根廷
- 南美洲其他地区
- 北美洲
第六章 竞争形势
- 公司简介
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Gilson, Inc.
- PerkinElmer, Inc.
- Restek Corporation
- Scion Instruments
- Shimadzu Corporation
- Thermo Fisher Scientific
- Waters Corporation
第七章 市场机会及未来趋势
The Autosamplers Market size is estimated at USD 1.42 billion in 2024, and is expected to reach USD 2 billion by 2029, growing at a CAGR of 7.05% during the forecast period (2024-2029).
The market has had a positive impact due to the pandemic. Due to an increase in the infectious disease COVID-19, there has also been a positive effect and growth in demand for various services, including chromatography technologies. Researchers are seeking both vaccination and treatment. Chromatography is a powerful laboratory-based analytical method that researchers are employing as the scientific community strives to understand the Sars-CoV-2 virus and develop better therapies, vaccines, and diagnostic tools to aid in the fight against the COVID-19 pandemic. For instance, in a study published by Clinical Chemistry and Laboratory Medicine in June 2020, liquid chromatography coupled with mass spectrometry was used to quantify redeliver in the blood plasma of a COVID-19 patient and, thus, provide data on its efficacy as a treatment for SARS-CoV-2.
Furthermore, a product of cholesterol oxidation was helpful in the combat against SARS-CoV-2, according to multiple published papers. A few patients responded well to the emergency antiviral drug, but SARS-CoV-2 needed a secure and efficient antiviral medication. The expanding significance of chromatographic systems in medical facilities, academic settings, and commercial settings demonstrates the technique's massive contribution to the development of research across various fields. For instance, according to an article published by Encyclopedia Journal, in September 2022, a solid foundation for an analytical platform capable of supporting the demanding requirements of the postgenomic and post-COVID-19 era is provided by a variety of powerful chromatographic instruments that are readily available and have extremely high sensitivity, resolution, and identification capacity. Thus, the increase in demand for various chromogenic systems in medical facilities due to the requirements in the postgenomic and post-COVID-19 era is positively impacting the autosampler market.
Specific factors driving the market growth include autosamplers' advantages, chromatography's growing importance in drug approval, and increasing food safety concerns. Autosamplers can do more than merely switch between samples to analyze them. They are designed to support the flexible and effective workflow in all areas, from lowering process order and sample information transcription errors to sophisticated sample cleaning and protection for analysis. According to an article published by ModuVision Technologies in September 2021, the two main reasons autosamplers are utilized are efficiency since many samples may be handled without the influence of lab employees and quality. The pharmaceutical industry is conducting extensive research to create a new drug, driving the demand for the finished product.
Furthermore, according to the International Journal of Pharmaceutical Research and Applications published in June 2022, chromatography is accepted as a susceptible and effective separation method. Chromatography, used in all research labs, the pharmaceutical industry, academic institutions, etc., is the foundation of separation science. Developing new drugs necessitates using an appropriate technique that enables scientists to evaluate drug molecules in the most exact, precise, and straightforward manner possible. Due to its higher product reliability, robustness, resolution, speed, and sensitivity, chromatographic procedures promote the productivity of chemical and instrumentation processes by providing more information. Thus, chromatography's increasing usage and growing importance in drug development is expected to accelerate market growth.
However, the lack of skilled professionals and limitations in the budget of small and mid-size market players are expected to restrain the market growth.
Autosamplers Market Trends
Pharmaceutical and Biotechnology Companies are Expected to Witness High Growth Over the Forecast Period
Autosamplers replace manual sampling and injection by automatically selecting a sample and inserting it into the inlets of the instrument. Factors driving the segment growth include the advantages of autosamplers in the companies and the growing importance of chromatography in drug approval. According to an article published by Rasayanika, in October 2020, chromatography techniques are used by the pharmaceutical industry for a variety of tasks, including identifying and analyzing samples for the presence of chemicals or trace elements, preparing large quantities of highly pure materials, separating chiral compounds, determining the purity of mixtures, identifying unknown compounds present, and also in drug development. According to Agilent Technologies, with the support of the highly adaptable High-performance liquid chromatography (HPLC) technique, (bio-)pharmaceutical researchers and production facilities can comprehensively characterize possible drug or treatment options and guarantee that the medications are produced securely and reliably. Thus, these features are expected to drive segmental growth in the market.
Moreover, with the increasing expenditure on R&D, this market in the pharmaceutical industry is expected to attain good growth over the forecast period. According to an article published by EP News Bureau, in February 2021, for companies investing in research for new treatments, chemical entities, or new biological entities to battle outbreaks, the government looked into a 200 percent weighted deduction and a special allocation for R&D in biopharmaceuticals. This increased foreign R&D investment even further. Such steps are investigated in upcoming grants or as a series of mini budgets supporting strategic development within a supportive regulatory environment. Advanced products by the key players are expected to promote segmental growth. For instance, ESI DX Autosamplers feature chemically inert construction and deliver contamination-free sampling for Thermo Scientific ICP-OES and ICP-MS instruments. Such product development by key players is expected to promote segmental growth in the market.
Therefore, the factors mentioned above are expected to drive segmental growth in the market during the forecast period.
North America is Expected to Dominate the Autosamplers Market
North America has dominated the global market studied, owing to the increased funding in R&D by the major market players, especially in the United States (U.S.). For instance, according to The State of U.S. Science and Engineering 2022, the United States spent USD 607.5 billion in R&D activity, with USD 101.1 billion (17%) of annual R&D spending classified as primary research. Similarly, the majority of R&D in the United States is funded by the business sector, and over 98% of that financing goes toward supporting commercial R&D activities. The second-largest source of R&D financing, accounting for around 21%, is the U.S. federal government, which funds research and development across all industries. The increase in funding for R&D in the U.S. is expected to drive the market.
Increasing product launches in the region are expected to drive the market in the region. For instance, in March 2022, Thermo Fisher Scientific launches a new GC/GC-MS instrument portfolio for increased efficiency. The GC/GC-MS instrument portfolio, including the new Thermo Scientific TRACE 1600 Series Gas Chromatograph, Thermo Scientific AI/AS 1610 Liquid Autosampler, Thermo Scientific ISQ 7610 Single Quadrupole GC-MS, and Thermo Scientific TSQ 9610 Triple Quadrupole GC-MS/MS, now features technological advances that enhance usability and productivity. Such product launches by various key players are expected to increase R&D investments into the pharmaceutical industry for drug discovery as well as production in the food & beverage industry, which in turn increased the demand for autosamplers in the region.
Autosamplers Industry Overview
The autosamplers market is consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known, including Agilent Technologies, Bio-Rad Laboratories, Inc., Gilson, Inc., PerkinElmer, Inc., Restek Corporation, Scion Instruments, Shimadzu Corporation, Thermo Fisher Scientific, Waters Corporation, among others, hold the substantial market share in the Autosamplers market., among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Various Advantages of Autosamplers Coupled with Growing Importance of Chromatography in Drug Approval
- 4.2.2 Increasing Food Safety Concerns
- 4.3 Market Restraints
- 4.3.1 Lack of Skilled Professionals
- 4.3.2 Limitations in Budget of Small and Mid-Size Market Players
- 4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
- 5.1 By Product
- 5.1.1 Systems
- 5.1.1.1 Liquid Chromatography Autosamplers
- 5.1.1.2 Gas Chromatography Autosamplers
- 5.1.2 Accessories
- 5.1.1 Systems
- 5.2 By End-User
- 5.2.1 Pharmaceutical and Biopharmaceutical Companies
- 5.2.2 Food and Beverage Industry
- 5.2.3 Environmental Testing Industry
- 5.2.4 Others
- 5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
- 5.3.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 Agilent Technologies, Inc.
- 6.1.2 Bio-Rad Laboratories, Inc.
- 6.1.3 Gilson, Inc.
- 6.1.4 PerkinElmer, Inc.
- 6.1.5 Restek Corporation
- 6.1.6 Scion Instruments
- 6.1.7 Shimadzu Corporation
- 6.1.8 Thermo Fisher Scientific
- 6.1.9 Waters Corporation
